First Tracks Biotherapeutics Stock

First Tracks Biotherapeutics Forward P/E

The Forward P/E Ratio of First Tracks Biotherapeutics (TRAX) as of Aug 8, 2026 is -3.66. In the previous year, Forward P/E Ratio was -3.71 — a change of -1.43% (higher).

Forward P/E

-3.66

YoY

-1.43%

Last updated:

Forward P/E Ratio of First Tracks Biotherapeutics is 2026 -3.66 . Forward P/E Ratio of First Tracks Biotherapeutics was 2025 -3.71 . It decreases by -1.43% higher compared to the previous year.
Access this data via the Eulerpool API

First Tracks Biotherapeutics Stock analysis

What does First Tracks Biotherapeutics do? First Tracks Biotherapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about First Tracks Biotherapeutics stock

Forward P/E Ratio of First Tracks Biotherapeutics is -3.66 in 2026.

Forward P/E Ratio of First Tracks Biotherapeutics changed from -3.71 to -3.66, representing a -1.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio First Tracks Biotherapeutics since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's First Tracks Biotherapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — First Tracks Biotherapeutics

All Key Metrics — First Tracks Biotherapeutics